PARALLAX HEALTH SCIENCES, INC.
company.status.inactiveCIK 1388410fmd_05GMX2WCA1NZZ7AM02GS6QHM25Services · Services-Health ServicesTemplate: Standard
Coverage: Jan 01, 2005 to Dec 31, 2019, 44 periods
Latest annual · FY2019
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (6)
- Net income
- (13)
Latest quarter · Q4 FY2019
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (6)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2016 to FY2019
- -82.2%
- Revenue, 5 yearsFY2014 to FY2019
- n/m
- Net income, 5 yearsFY2014 to FY2019
- n/m
PARALLAX HEALTH SCIENCES, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Revenue | $128,600 | $11,739 | +995.5% | 10-K/A 2020-05-20 · proof |
| Gross profit | $111,773 | -$8,600 | 10-K/A 2020-05-20 · proof | |
| Operating income | -$6.4 million | -$6.6 million | 10-K/A 2020-05-20 · proof | |
| Net income | -$12.9 million | $14.8 million | -187% | 10-K/A 2020-05-20 · proof |
| Cash from operating activities | -$2.9 | -$1.3 million | 10-K/A 2020-05-20 · proof | |
| Total assets | $1.4 million | $1.4 million | -0.3% | 10-K/A 2020-05-20 · proof |
| Total liabilities | $11.6 million | $7.3 million | +58.8% | 10-K/A 2020-05-20 · proof |
| Cash and cash equivalents | $6,445 | $262 | +2,359.9% | 10-K/A 2020-05-20 · proof |
- What was PARALLAX HEALTH SCIENCES, INC.'s revenue in fiscal 2019?
- PARALLAX HEALTH SCIENCES, INC. reported revenue of $128,600 for fiscal 2019 (the year ended Dec 31, 2019), against $11,739 the year before (+995.5%). Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What was PARALLAX HEALTH SCIENCES, INC.'s gross profit in fiscal 2019?
- PARALLAX HEALTH SCIENCES, INC. reported gross profit of $111,773 for fiscal 2019 (the year ended Dec 31, 2019), against -$8,600 the year before. Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What was PARALLAX HEALTH SCIENCES, INC.'s operating income in fiscal 2019?
- PARALLAX HEALTH SCIENCES, INC. reported operating income of -$6.4 million for fiscal 2019 (the year ended Dec 31, 2019), against -$6.6 million the year before. Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What was PARALLAX HEALTH SCIENCES, INC.'s net income in fiscal 2019?
- PARALLAX HEALTH SCIENCES, INC. reported net income of -$12.9 million for fiscal 2019 (the year ended Dec 31, 2019), against $14.8 million the year before (-187%). Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What was PARALLAX HEALTH SCIENCES, INC.'s cash from operating activities in fiscal 2019?
- PARALLAX HEALTH SCIENCES, INC. reported cash from operating activities of -$2.9 for fiscal 2019 (the year ended Dec 31, 2019), against -$1.3 million the year before. Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What are PARALLAX HEALTH SCIENCES, INC.'s total assets?
- As of Dec 31, 2019, PARALLAX HEALTH SCIENCES, INC. reported total assets of $1.4 million, against $1.4 million a year earlier (-0.3%). Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What are PARALLAX HEALTH SCIENCES, INC.'s total liabilities?
- As of Dec 31, 2019, PARALLAX HEALTH SCIENCES, INC. reported total liabilities of $11.6 million, against $7.3 million a year earlier (+58.8%). Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
- What are PARALLAX HEALTH SCIENCES, INC.'s cash and cash equivalents?
- As of Dec 31, 2019, PARALLAX HEALTH SCIENCES, INC. reported cash and cash equivalents of $6,445, against $262 a year earlier (+2,359.9%). Source: the 10-K/A filed with the SEC on May 20, 2020. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1388410&period_type=annual&limit=5"Information only, not investment advice.